a well-established setup:
- RX7 and RX9 are progressing cost-free through the NHI program in the USA.
- A grant has been secured for continuing pre-clinical work on MDMA.
- Reach Wellness is funding the enrollment of 50 people, allowing the capture of real-world data (RWD).
- Clinical services are operating efficiently.
a well-established setup:RX7 and RX9 are progressing cost-free...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.4¢ |
Change
-0.001(2.86%) |
Mkt cap ! $13.90M | |||
| Open | High | Low | Value | Volume |
| 3.4¢ | 3.5¢ | 3.4¢ | $4.525K | 132.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 436779 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 15.56pm 16/08/2024 (20 minute delay) ? |
| EMD (ASX) Chart |